Phibro Animal Health (PAHC) Net Cash Flow Growth (5y) (2018 - 2026)
Analysis
Phibro Animal Health (PAHC) Net Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.43% |
| Mar 31, 2026 | -17.02% |
| Dec 31, 2025 | -52.02% |
| Sep 30, 2025 | 23.25% |
| Jun 30, 2025 | -7.05% |
| Mar 31, 2025 | -43.17% |
| Dec 31, 2024 | 21.53% |
| Sep 30, 2024 | -55.14% |
| Jun 30, 2024 | -0.48% |
| Mar 31, 2024 | 29.78% |
| Dec 31, 2023 | -27.74% |
| Sep 30, 2023 | 21.83% |
| Jun 30, 2023 | 50.87% |
| Mar 31, 2023 | -26.25% |
| Dec 31, 2022 | 17.03% |
| Sep 30, 2022 | -15.73% |
| Jun 30, 2022 | -8.31% |
| Mar 31, 2022 | -8.31% |
| Dec 31, 2021 | 62.82% |
| Sep 30, 2021 | -33.24% |